#  Clinical Trial Data analysis 


## Case 1: Feasibility analysis
There are 2 files
1. a simplified sample protocol
2. a simplified sample claims data
Please use the provided sample claims data to help with this study.

Questions:

- How many patients have been diagnosed with Non-Small Cell Lung Cancer?
- Where can you find them?
- Is this protocol feasible based on this claims data?
- Any other questions that you can provide answers to based on the sample data?
Please do share the Python/SQL code you use to process the sample data.


[Python/SQL code used] (https://colab.research.google.com/drive/1Z3O3AiANfRFij1KKp_x42ZiAJPGg-2Vh)



##Case study 2:

Consider that you’re a part of a big pharma’s R&D organization and involved in the preparation of a novel Phase III clinical trial in Breast Cancer. The company wants to optimize the overall country selection strategy for the designated clinical trial to be able to expedite the patient recruitment within 12 months’ time. Please review the attached blinded protocol synopsis. Using your understanding and statistical approach, develop a tactical roadmap for the trial footprint including clear logical inputs, rationale and data sources used for each query

- Which countries to be considered
- What factors to be considered
- Challenges foreseen in conducting the trial by country

[Excel with country ranking](https://docs.google.com/spreadsheets/d/1pwivOL_N0N3kiqw-gFa4cNrnmVQIxxk-h17qFqbBaLM/edit?usp=sharing)



[Presentation with main findings] (https://docs.google.com/presentation/d/1gUqLhbAKy6wA-dA9erePMw74BX_x15eRdQLgWa5s16Q/edit?usp=sharing)
